Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M A Marshall

Showing results (1-10 of 8) with videos related to

Pageof 1
Sort By:
Science (New York, N.Y.)|June 16, 1989
Genetic engineering of filamentous fungiW E Timberlake, M A Marshall
Molecular and Cellular Biology|January 1, 1991
Aspergillus nidulans wetA activates spore-specific gene expressionM A Marshall, W E Timberlake
The Journal of the American Osteopathic Association|August 16, 2000
Factors associated with the vaccination of international travelers: a multivariate analysisJ C Licciardone, K M Herron, M A Marshall, et al.
Microbes and Infection|November 16, 2001
Mice infected with Schistosoma mansoni develop a novel non-T-lymphocyte suppressor population which inhibits virus-specific CTL induction via a soluble factorM A Marshall, D Jankovic, V E Maher, et al.
The Journal of Infectious Diseases|March 18, 2000
Growth-inhibiting antibody responses of humans vaccinated with recombinant outer surface protein A or infected with Borrelia burgdorferi or bothC J Luke, M A Marshall, J M Zahradnik, et al.
European Journal of Immunology|December 1, 1994
Increased susceptibility of mice infected with Schistosoma mansoni to recombinant vaccinia virus: association of viral persistence with egg granuloma formationJ K Actor, M A Marshall, I A Eltoum, et al.
British Journal of Cancer|May 9, 2013
Phase I study of tremelimumab (CP-675 206) plus PF-3512676 (CPG 7909) in patients with melanoma or advanced solid tumoursM Millward, C Underhill, S Lobb, et al.
Cancer Research|September 1, 1996
Interleukin 2 production in vitro by peripheral lymphocytes in response to human papillomavirus-derived peptides: correlation with cervical pathologyT Tsukui, A Hildesheim, M H Schiffman, et al.
Pageof 1

Showing results (1-10 of 8) with videos related to

Sort By:
Pageof 1
Science (New York, N.Y.)|June 16, 1989
Genetic engineering of filamentous fungiW E Timberlake, M A Marshall
Molecular and Cellular Biology|January 1, 1991
Aspergillus nidulans wetA activates spore-specific gene expressionM A Marshall, W E Timberlake
The Journal of the American Osteopathic Association|August 16, 2000
Factors associated with the vaccination of international travelers: a multivariate analysisJ C Licciardone, K M Herron, M A Marshall, et al.
Microbes and Infection|November 16, 2001
Mice infected with Schistosoma mansoni develop a novel non-T-lymphocyte suppressor population which inhibits virus-specific CTL induction via a soluble factorM A Marshall, D Jankovic, V E Maher, et al.
The Journal of Infectious Diseases|March 18, 2000
Growth-inhibiting antibody responses of humans vaccinated with recombinant outer surface protein A or infected with Borrelia burgdorferi or bothC J Luke, M A Marshall, J M Zahradnik, et al.
European Journal of Immunology|December 1, 1994
Increased susceptibility of mice infected with Schistosoma mansoni to recombinant vaccinia virus: association of viral persistence with egg granuloma formationJ K Actor, M A Marshall, I A Eltoum, et al.
British Journal of Cancer|May 9, 2013
Phase I study of tremelimumab (CP-675 206) plus PF-3512676 (CPG 7909) in patients with melanoma or advanced solid tumoursM Millward, C Underhill, S Lobb, et al.
Cancer Research|September 1, 1996
Interleukin 2 production in vitro by peripheral lymphocytes in response to human papillomavirus-derived peptides: correlation with cervical pathologyT Tsukui, A Hildesheim, M H Schiffman, et al.
Pageof 1